Xenitra Limited has released a press release.
$12M offtake agreement with leading OTC-pharmaceutical
Earlier from Xenitra
- $1.1m in OPAL-Tokenised Product Sales in First 7 Weeks
- XEN Appointed as Exclusive Biomiq Skincare China Distributor
- Product sales of $500k in first month of OPAL token launch
- $1.25m Raised to Support Next Phase of Growth